期刊
SCIENTIFIC REPORTS
卷 12, 期 1, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41598-022-11205-9
关键词
-
资金
- Netherlands Organisation for Scientific Research (NWO) [731.015.414]
- Helmholtz Association's Initiative and Networking Fund
- European Union [860816]
- Marie Curie Actions (MSCA) [860816] Funding Source: Marie Curie Actions (MSCA)
The development of drug resistance highlights the importance of new antibiotics. Most bacteria synthesize isoprenoid precursors through the MEP pathway, making 1-deoxy-d-xylulose 5-phosphate synthase (DXPS) an attractive target. In this study, the DXPS structure of the pathogenic bacteria Mycobacterium tuberculosis was successfully solved using a loop truncation method, revealing differences and new insights into the stabilization mechanism of the enamine intermediate. The findings provide an opportunity for structure-based drug design to develop specific inhibitors for M. tuberculosis DXPS.
The development of drug resistance by Mycobacterium tuberculosis and other pathogenic bacteria emphasizes the need for new antibiotics. Unlike animals, most bacteria synthesize isoprenoid precursors through the MEP pathway. 1-Deoxy-d-xylulose 5-phosphate synthase (DXPS) catalyzes the first reaction of the MEP pathway and is an attractive target for the development of new antibiotics. We report here the successful use of a loop truncation to crystallize and solve the first DXPS structures of a pathogen, namely M. tuberculosis (MtDXPS). The main difference found to other DXPS structures is in the active site where a highly coordinated water was found, showing a new mechanism for the enamine-intermediate stabilization. Unlike other DXPS structures, a fork-like motif could be identified in the enamine structure, using a different residue for the interaction with the cofactor, potentially leading to a decrease in the stability of the intermediate. In addition, electron density suggesting a phosphate group could be found close to the active site, provides new evidence for the D-GAP binding site. These results provide the opportunity to improve or develop new inhibitors specific for MtDXPS through structure-based drug design.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据